These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 1251927)

  • 1. The dopamine hypothesis of schizophrenia: focus on the dopamine receptor.
    Snyder SH
    Am J Psychiatry; 1976 Feb; 133(2):197-202. PubMed ID: 1251927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward hypotheses for a biochemical component in the vulnerability to schizophrenia.
    Kety SS
    Semin Psychiatry; 1972 Aug; 4(3):233-8. PubMed ID: 4155537
    [No Abstract]   [Full Text] [Related]  

  • 3. The relationship between epilepsy and schizophrenia: a biochemical hypothesis.
    Trimble M
    Biol Psychiatry; 1977 Apr; 12(2):299-304. PubMed ID: 15665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amphetamine psychosis: a "model" schizophrenia mediated by catecholamines.
    Snyder SH
    Am J Psychiatry; 1973 Jan; 130(1):61-7. PubMed ID: 4345465
    [No Abstract]   [Full Text] [Related]  

  • 5. Amphetamine psychosis: overview and a hypothesis.
    Siomopoulos V
    Dis Nerv Syst; 1975 Jun; 36(6):336-9. PubMed ID: 1149593
    [No Abstract]   [Full Text] [Related]  

  • 6. Antipsychotic drug actions: a clue to the neuropathology of schizophrenia?
    Matthysse S
    Fed Proc; 1973 Feb; 32(2):200-5. PubMed ID: 4348519
    [No Abstract]   [Full Text] [Related]  

  • 7. [Schizophrenia as a dopamine excess syndrome].
    Toru M
    Nihon Rinsho; 1983 May; 41(5):1021-7. PubMed ID: 6138444
    [No Abstract]   [Full Text] [Related]  

  • 8. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs.
    Creese I; Burt DR; Snyder SH
    Science; 1976 Apr; 192(4238):481-3. PubMed ID: 3854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amphetamine psychosis: behavioral and biochemical aspects.
    Angrist B; Sathananthan G; Wilk S; Gershon S
    J Psychiatr Res; 1974; 11():13-23. PubMed ID: 4461784
    [No Abstract]   [Full Text] [Related]  

  • 10. Epilepsy and schizophrenia: a neurochemical bridge.
    Lamprecht F
    J Neural Transm; 1977; 40(2):159-70. PubMed ID: 140216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine and the pharmacology of schizophrenia: the state of the evidence.
    Matthysse S
    J Psychiatr Res; 1974; 11():107-13. PubMed ID: 4218872
    [No Abstract]   [Full Text] [Related]  

  • 12. The dopamine hypothesis of schizophrenia. A critical analysis.
    Luchins D
    Neuropsychobiology; 1975; 1(6):365-78. PubMed ID: 1234325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of thioproperazine on dopamine and noradrenaline metabolism in chronic schizophrenia].
    Panisset VC; Albert JM; Rocheleau LP; Dhaiti G; Tétreault L
    Laval Med; 1970 Sep; 41(7):917-22. PubMed ID: 4396422
    [No Abstract]   [Full Text] [Related]  

  • 14. Biochemistry and the schizophrenia. Old concepts and new hypothesis.
    Berger PA
    J Nerv Ment Dis; 1981 Feb; 169(2):90-9. PubMed ID: 7009786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haloperidol and the butyrophenones.
    Ban TA
    Psychosomatics; 1973; 14(5):286-97. PubMed ID: 4604517
    [No Abstract]   [Full Text] [Related]  

  • 16. Catecholamines in the brain as mediators of amphetamine psychosis.
    Snyder SH
    Arch Gen Psychiatry; 1972 Aug; 27(2):169-79. PubMed ID: 4339577
    [No Abstract]   [Full Text] [Related]  

  • 17. Does dopamine have a role in schizophrenia?
    Carlsson A
    Biol Psychiatry; 1978 Feb; 13(1):3-21. PubMed ID: 341997
    [No Abstract]   [Full Text] [Related]  

  • 18. Evidence for a noradrenergic mechanism in the grooming produced by (+)-amphetamine and 4, alpha-dimethyl-m-tyramine (H 77/77) in rats.
    Lassen JB
    Psychopharmacology (Berl); 1977 Oct; 54(2):153-7. PubMed ID: 144928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychoactive drugs and brain neurochemical transmitters.
    Valzelli L
    Arch Int Pharmacodyn Ther; 1972 Apr; 196():Suppl 196:221+. PubMed ID: 4342945
    [No Abstract]   [Full Text] [Related]  

  • 20. Amphetamine-induced psychosis--a separate diagnostic entity or primary psychosis triggered in the vulnerable?
    Bramness JG; Gundersen ØH; Guterstam J; Rognli EB; Konstenius M; Løberg EM; Medhus S; Tanum L; Franck J
    BMC Psychiatry; 2012 Dec; 12():221. PubMed ID: 23216941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.